contentSlug

type

ContentSlug_ContentQuery

slug

ContentPageContentQuery

content

trendingContent

query ContentSlug_ContentQuery(
  $contentSlug: String!
  $type: [ContentType!]
) {
  ...ContentPageContentQuery_13QmVO
}

fragment CompanyDetails_Content on Content {
  __isContent: __typename
  companies {
    name
    description
    pageUrl
    id
  }
}

fragment ContentBasicInfo on Content {
  __isContent: __typename
  id
  type
  title
  lang
  companies {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  tags {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  ...PublishingDetails
  ...Reactions
}

fragment ContentMetadata on Content {
  __isContent: __typename
  type
  title
  lang
  pageUrl
  alternatePageUrls: translations {
    __typename
    pageUrl
    lang
  }
  imgUrl
  description
  ... on Video {
    liveTime
    videoUrl
  }
  ... on Webcast {
    liveTime
    videoUrl
  }
}

fragment ContentPageContentQuery_13QmVO on Query {
  content(slug: $contentSlug, type: $type) {
    __typename
    id
    type
    title
    isPremium
    lang
    htmlBody
    summary
    companies {
      forum {
        latestPosts {
          ...ForumPosts
        }
      }
      name
      id
      viewerIsFollowing
      pageUrl
      defaultInstrument {
        isin
        id
        marketOpen
        marketClose
        marketplace {
          region
        }
        returns {
          total
        }
      }
    }
    tags {
      viewerIsFollowing
      id
      name
      pageUrl
    }
    createdAt
    ... on Video {
      liveTime
    }
    ... on Webcast {
      liveTime
    }
    slug
    ... on CompanyReport {
      reportUrl
    }
    ... on ThirdPartyCompanyReport {
      reportUrl
    }
    ... on StockExchangeRelease {
      reportUrl
    }
    ...ContentBasicInfo
    ...ContentMetadata
    ...PriceAndRecommendation_Content
    ...CompanyDetails_Content
    ...ReportLink_Content
    ...KeyFigures_Content
  }
  ...TrendingContent_1jQ2Cn
}

fragment ForumPosts on ForumPost {
  text
  likesCount
  url
  author
  postedAt
  authorImgUrl
}

fragment KeyFigures_Content on Content {
  __isContent: __typename
  companies {
    defaultInstrument {
      estimateData {
        modelType
        reportingCurrency
      }
      snapshot {
        transaction {
          date
          actualized {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
          estimates {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
        }
      }
      id
    }
    id
  }
}

fragment PriceAndRecommendation_Content on Content {
  __isContent: __typename
  createdAt
  companies {
    name
    pageUrl
    defaultInstrument {
      priceData {
        tradeCurrency
      }
      snapshot {
        priceData {
          date
          lastPrice
          tradeCurrency
        }
        transaction {
          date
          recommendation
          targetPrice
        }
        prevTransaction {
          recommendation
        }
      }
      id
    }
    id
  }
}

fragment PublishingDetails on Content {
  __isContent: __typename
  createdAt
  publishers {
    name
    imgUrl
  }
  authors {
    __typename
    id
    name
    slug
    imgUrl
    jobTitle
  }
  ... on Video {
    liveTime
  }
  ... on Webcast {
    liveTime
  }
}

fragment Reactions on Content {
  __isContent: __typename
  id
  reactionGroups {
    reactionType
    reactionsCount
    viewerReacted
  }
}

fragment ReportLink_Content on Content {
  __isContent: __typename
  type
  isPremium
  ... on CompanyReport {
    reportUrl
  }
  ... on ThirdPartyCompanyReport {
    reportUrl
  }
  ... on StockExchangeRelease {
    reportUrl
  }
}

fragment TrendingContent_1jQ2Cn on Query {
  trendingContent(type: ARTICLE) {
    __typename
    id
    title
    lang
    pageUrl
    createdAt
    type
    imgUrl
    companies {
      squareLogoUrl
      name
      id
    }
    authors {
      __typename
      imgUrl
      id
    }
    publishers {
      imgUrl
    }
  }
}


neola-medical-invites-to-presentation-of-the-q4-report-2024

__typename

title

isPremium

lang

htmlBody

summary

companies

createdAt

publishers

authors

reactionGroups

pageUrl

translations

imgUrl

description

Neola Medical operates in the medical technology sector. The company focuses on neonatal care, where it develops medical equipment. Examples of products that the company provides to the healthcare sector include technical monitoring and follow-up of lung capacity in premature infants. In addition to the main product, ancillary products and disposables are offered. The largest operations are found in the Nordic market. Neola Medical was founded in 2016 and is headquartered in Sweden.

Neola Medical

Neola Medical AB (publ) invites to presentation of the Q4-report of 2024, Wednesday the 12th of February 2025 at 11:00 CET (11.00). The presentation will be held online as a webcast hosted by...

<div class="mfn-preamble"><p><strong>Neola Medical AB (publ) invites to presentation of the Q4-report of 2024, Wednesday the 12th of February 2025 at 11:00 CET (11.00). The presentation will be held online as a webcast hosted by Finwire. The Q4-report will be published the same morning.</strong></p></div><div class="mfn-body"><p>Neola Medical publishes the Q4-report in the morning the 12th of February 2025. We hereby invite investors, analysts, and journalists to a combined report presentation and webcast Wednesday the 12th of February 2025 at 11:00 CET (11.00). The report will be presented by CEO Hanna Sjöström and CFO David Folkesson.</p><p>Watch the presentation here: <a rel="noopener" href="https://www.google.com/url?q=https%3A%2F%2Fwww.finwire.tv%2Fwebcast%2Fneola-medical%2Fyear-end-report%2F&amp;sa=D&amp;ust=1737804120000000&amp;usg=AOvVaw2g594pLNYINsWsIpjvOgXS">https://www.finwire.tv/webcast/neola-medical/year-end-report/</a> where you also can type in questions in advance and during the presentation that we will be answering live during the Q&amp;A after the presentation.</p><p>For further questions after the presentation, contact CFO David Folkesson through below contact details.</p><p>The report and report presentation will be available at Neola Medical’s website:<br><a rel="noopener" href="https://www.neolamedical.com/investors/rapporter-och-finansiell-kalender/">https://www.neolamedical.com/investors/rapporter-och-finansiell-kalender/</a></p></div><div class="mfn-footer mfn-c97fc7146005"><p><strong class="mfn-heading-1">For further information, contact:</strong><br>Hanna Sjöström, CEO<br>e-mail: <a rel="noopener" href="mailto:hanna.sjostrom@neolamedical.com">hanna.sjostrom@neolamedical.com</a><br>David Folkesson, CFO<br>e-mail: <a rel="noopener" href="mailto:christian.gyllenberg@neolamedical.com">david.folkesson@neolamedical.com</a></p></div><div class="mfn-footer mfn-about mfn-112561f0eca8"><p><strong class="mfn-heading-1">About Neola Medical</strong><br>Neola Medical AB (publ) develops revolutionizing medical technology device for non-invasive continuous lung monitoring and real-time alerts of life-threatening lung complications of preterm born infants. Immediate detection of complications provides the possibility of early treatment, improved health care and healthier lives for preterm born infants. The patented cutting-edge technology is developed at Lund University in Sweden and based on a spectroscopic method that measures lung volume changes and oxygen gas concentration. Neola Medical is building on a historic Swedish legacy of medical technology innovation and invaluable contributions to global health care. The company was founded in 2016 and is listed on NASDAQ First North Growth Market (ticker: NEOLA). Read more at www.neolamedical.com. The company’s Certified Adviser is FNCA Sweden AB.</p></div><div class="mfn-footer mfn-attachment mfn-attachment-general"><p><strong class="mfn-heading-1">Attachments</strong><br><a rel="noopener" href="https://storage.mfn.se/c0758101-bfd8-4d05-9a33-8ebfa5d56c5a/neola-medical-invites-to-presentation-of-the-q4-report-2024.pdf" class="mfn-generated mfn-primary">Neola Medical invites to presentation of the Q4-report 2024</a></p></div>

Neola Medical invites to presentation of the Q4-report 2024

Talouden myyttejä murtamassa: Saksan teollisuus on menneen talven lumia

Federal Reserven korkopäätös: Riidankylväjät vauhdissa

On pakko painaa pitkää päivää? Ekonomisti fundeeraa

Taloustieteen myyttejä murtamassa: Datakeskusinvestoinnit johtavat aina vain parempaan tekoälyyn

Nousuviikko takana, USA:n työllisyystaantuma ei edelleenkään luvuissa